AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT03191240
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT03191240
-
- Other papers using this trial's data
- Diastolic blood pressures and end tidal carbon dioxides during cardiopulmonary resuscitations and their association with outcomes in adult out-of-hospital cardiac arrest patients: A preplanned secondary analysis of the Augmented Medication CardioPulmonary resuscitation (AMCPR) trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03191240. Randomized; triple masking; primary purpose treatment. Start 2017-12-31 (actual); primary completion 2021-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
- Condition
- Out-of-Hospital Cardiac Arrest
- Intervention (Drug)
- Vasopressins
- Intervention (Drug)
- Normal saline
- Lead sponsor
- Asan Medical Center
Record details
- Record id
cardio:ct-nct03191240- Content hash
7c46a3b708089f89ad48d9c24abcb53dba0f798ef91b0bb7ad74ccad3fc1f46c